Output Factors and dose profiles measurements performed, respectively, with the PSD and the PSDCA were in agreement with those obtained with the UD and EBT2 films. For stereotactic radiosurgery treatment verification, the PSD gives accurate results compared to the planning system and the IC once the latter is corrected to compensate for the averaging effect of the IC. The PSD provides precise results when used as a single detector or in a dense array, resulting in a great potential for stereotactic radiosurgery QA measurements.
Purpose: To compare the performance of a plastic scintillation detector (PSD) for quality assurance (QA) in stereotactic radiosurgery to micro‐chamber, gafchromic films, shielded and unshielded diodes. Method and Materials: The PSD consists of a 1 mm diameter by 1 mm long scintillating fiber (BCF‐60, Saint‐Gobain Inc.) coupled to a polymethyl‐methacrylate optical fiber (Eska premier, Mitsubitshi). Output factors and dose profiles for apertures used in radiosurgery ranging from 4 mm to 40 mm in diameter have been measured with the PSD, a micro‐chamber (MC) (A16, Exradin), a shielded diode (SD) (type 60008, PTW), an unshielded diode (UD) (SFD stereotactic, IBA Dosimetry) and gafchromic EBT films. Moreover, a typical stereotactic radiosurgery treatment using 4 non‐coplanar arcs was delivered on a spherical phantom in which UD, MC or PSD was placed. Using the Xknife planning system (Radionics), 15 Gy was prescribed at the isocenter, where each detector was positioned. Results: The output factors measured with the PSD are within a maximum discrepancy of 3.5% compared to UD for the small apertures when normalized to the 35 mm cone. For larger cones the PSD is within 1.3% compared to the SD and the MC. When done with a 35 mm cone, the measured dose for an entire typical stereotactic plan by the PSD is within 1.8% of the measurement performed using the MC and within 1% of the planning system. Volume averaging of the MC can be observed for the 5 mm aperture, where the PSD measurement differs by as much as 9.1%. Conclusion: For stereotactic radiosurgery treatment verification, the PSD gives accurate results compared to the MC once the output factor ratio of both dosimeters are taken into account to correct for the averaging effect of the MC. The PSD shows great potential for stereotactic radiosurgery QA measurements.
Purpose: To compare the performance of a plastic scintillation detector (PSD) for quality assurance (QA) in stereotactic radiosurgery to micro‐chamber (MC), gafchromic films, shielded diode (SD) and unshielded diodes (UD). Method and Materials: The PSD consists of a 1 mm diameter by 1 mm long scintillating fiber coupled to a polymethyl‐methacrylate optical fiber. Output factors and dose profiles for apertures used in radiosurgery have been measured. Moreover, a typical stereotactic radiosurgery treatment, using four non‐coplanar arcs, was delivered on a spherical phantom in which UD, MC or PSD was placed at the isocenter, where 15 Gy was prescribed. Results: The output factors measured with the PSD are within a mean discrepancy of 1 % compared to UD for the small apertures when normalized to the 35 mm cone. For larger cones the PSD is within 1.3% compared to the SD and the MC. When done with a 35 mm cone, the measured dose for an entire typical stereotactic plan by the PSD is within 1.8% of the measurement performed using the MC and within 1% of the planning system. Volume averaging of the MC can be observed for the 5 mm aperture, where the PSD measurement differs by as much as 9.1%. Conclusion: For stereotactic radiosurgery treatment verification, the PSD gives accurate results compared to the MC once the output factor ratio are taken into account to correct for the averaging effect of the MC. The PSD shows great potential for stereotactic radiosurgery QA measurements.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.